We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $58.9B
1-Year Est. Return 51.73%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+51.73%
3 Year Est. Return
+168.58%
5 Year Est. Return
+213.54%
10 Year Est. Return
+865.31%
AUM
$50.7B
AUM Growth
-$15.2B
Cap. Flow
-$465M
Cap. Flow %
-0.92%
Top 10 Hldgs %
39.98%
Holding
1,934
New
364
Increased
545
Reduced
471
Closed
329

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.43%
2 Technology 1.29%
3 Financials 1.28%
4 Consumer Discretionary 0.7%
5 Industrials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
1151
KeyCorp
KEY
$23.3B
$649K ﹤0.01%
+31,437
New +$585K
HTZ icon
1152
PUT
Hertz
HTZ
$781M
$648K ﹤0.01%
126,000
CNX icon
1153
CALL
CNX Resources
CNX
$5.48B
$647K ﹤0.01%
17,600
-8,000
-31% -$286K
TMO icon
1154
Thermo Fisher Scientific
TMO
$223B
$647K ﹤0.01%
+1,116
New +$631K
BGS icon
1155
B&G Foods
BGS
$268M
$645K ﹤0.01%
150,000
KEEL
1156
PUT
Keel Infrastructure Corp
KEEL
$2.3B
$636K ﹤0.01%
270,800
-420,300
-61% -$1.44M
OHI icon
1157
Omega Healthcare
OHI
$14.3B
$636K ﹤0.01%
+14,336
New +$618K
NNE
1158
Nano Nuclear Energy
NNE
$1.04B
$634K ﹤0.01%
26,400
+22,770
+627% +$872K
BTI icon
1159
PUT
British American Tobacco
BTI
$119B
$617K ﹤0.01%
10,900
-300
-3% -$16.4K
DJT icon
1160
CALL
Trump Media & Technology Group
DJT
$2.57B
$617K ﹤0.01%
46,600
-303,400
-87% -$4.14M
ARKG icon
1161
ARK Genomic Revolution ETF
ARKG
$2.01B
$610K ﹤0.01%
21,069
-2,184
-9% -$65.6K
HYG icon
1162
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
$605K ﹤0.01%
7,500
-793,000
-99% -$63.9M
KBE icon
1163
State Street SPDR S&P Bank ETF
KBE
$1.59B
$604K ﹤0.01%
9,956
+9,955
+995,500% +$586K
ARKG icon
1164
CALL
ARK Genomic Revolution ETF
ARKG
$2.01B
$600K ﹤0.01%
+20,700
New +$621K
LEU icon
1165
Centrus Energy
LEU
$3.7B
$597K ﹤0.01%
2,460
-4,894
-67% -$1.48M
LOW icon
1166
Lowe's Companies
LOW
$113B
$596K ﹤0.01%
2,472
+788
+47% +$189K
MRNA icon
1167
CALL
Moderna
MRNA
$56B
$590K ﹤0.01%
20,000
-100,000
-83% -$2.72M
MRNA icon
1168
PUT
Moderna
MRNA
$56B
$587K ﹤0.01%
19,900
-124,900
-86% -$3.39M
BBY icon
1169
Best Buy
BBY
$18.7B
$577K ﹤0.01%
+8,619
New +$658K
CPNG icon
1170
Coupang
CPNG
$26.6B
$577K ﹤0.01%
24,454
-59,728
-71% -$1.7M
SPGI icon
1171
S&P Global
SPGI
$127B
$568K ﹤0.01%
1,087
+31
+3% +$15.3K
AGNC icon
1172
AGNC Investment
AGNC
$12.7B
$568K ﹤0.01%
52,972
+17,967
+51% +$185K
DLO icon
1173
CALL
dLocal
DLO
$4.4B
$566K ﹤0.01%
40,000
NTNX icon
1174
Nutanix
NTNX
$18.2B
$564K ﹤0.01%
10,919
-14,189
-57% -$867K
FXE icon
1175
Invesco CurrencyShares Euro Currency Trust
FXE
$370M
$562K ﹤0.01%
5,180

Similar funds

Parallax Volatility Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Parallax Volatility Advisers held 1,934 positions worth $50.7B, down 23% from $65.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Parallax Volatility Advisers's Q4 2025 filing shows 364 new, 545 increased, 471 reduced and 329 closed positions. Its largest new stake was American Express: 733,883 shares worth $272M. The largest sale was Meta Platforms (Facebook), an estimated $191M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Technology and Financials.

  • Parallax Volatility Advisers's largest Q4 2025 buy was American Express: 733,883 shares worth $272M.
  • Parallax Volatility Advisers added most to Alibaba in Q4 2025, an estimated $47.6M increase.
  • Parallax Volatility Advisers's biggest Q4 2025 reduction was SPDR Gold Trust, cutting an estimated $80.5M.
  • Parallax Volatility Advisers fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $191M.
  • Parallax Volatility Advisers's ten largest holdings make up 40% of its $50.7B portfolio in Q4 2025.
  • Parallax Volatility Advisers opened 364 new positions and closed 329 in Q4 2025.
  • Parallax Volatility Advisers's portfolio value fell 23% quarter-over-quarter to $50.7B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.